Novel Involvement of the Immunomodulator AS101 in IL-10 Signaling, via the Tyrosine Kinase Fer

:  Interleukin‐10 (IL‐10) plays a major proliferative role in many tumors, and activates the transcription factor Stat3 by tyrosine phosphorylation. The immunomodulator ammonium trichloro (dioxoethylene‐o,o') tellurate (AS101) has a direct antitumor activity, and is able to sensitize several tu...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the New York Academy of Sciences 2007-01, Vol.1095 (1), p.240-250
Hauptverfasser: HAYUN, RAMI, SHPUNGIN, SALI, MALOVANI, HANA, ALBECK, MICHAEL, OKUN, EITAN, NIR, URI, SREDNI, BENJAMIN
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung::  Interleukin‐10 (IL‐10) plays a major proliferative role in many tumors, and activates the transcription factor Stat3 by tyrosine phosphorylation. The immunomodulator ammonium trichloro (dioxoethylene‐o,o') tellurate (AS101) has a direct antitumor activity, and is able to sensitize several tumors to chemotherapy, by inhibiting the tumor IL‐10 autocrine loop. The tyrosine kinase Fer is essential for the proliferation of numerous malignant cell lines and in some cases was related to Stat3 activation. This article examined the role of AS101 in IL‐10 signaling, and the correlation between Fer and Stat3, in human peripheral blood mononuclear cells (PBMC). We show that Fer was associated with Stat3 in PBMC and RAW 264.7, a macrophage cell line. Recombinant IL‐10 (rIL‐10) increased the tyrosine phosphorylation of Stat3, upregulated the levels of Fer, and increased the association of Fer with phosphorylated Stat3 (pYStat3). All the activities of IL‐10 mentioned above were reversed by AS101. The effects conferred by AS101 were totally abolished by exogenous addition of rIL‐10. These results indicate that AS101 downregulates the Stat3 IL‐10 loop, and inhibits Fer association with pYStat3. We conclude that anti‐IL‐10 treatment using AS101, may be beneficial in certain malignancies and other pathologies in which IL‐10 secretion is elevated and Stat3 is continuously phosphorylated.
ISSN:0077-8923
1749-6632
1930-6547
DOI:10.1196/annals.1397.028